Tissue microarray-based evaluation of chromatin assembly factor-1 (CAF-1)/p60 as tumour prognostic marker

International Journal of Molecular Sciences

Volumn 13, Issue 9, 2012, Pages 11044-11062

  Mascolo, Massimo ^a   Ilardi, Gennaro ^a   Merolla, Francesco ^a   Russo, Daniela ^a   Vecchione, Maria Luisa ^a   de Rosa, Gaetano ^a   Staibano, Stefania ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Cancer screening; Chromatin assembly factor 1; Immunohistochemistry; Tissue microarray

Indexed keywords

BIOLOGICAL MARKER; CHROMATIN ASSEMBLY FACTOR 1; PROTEIN P60; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SCREENING; CANCER STAGING; CLINICAL FEATURE; DISEASE MARKER; FEMALE; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA SKIN CANCER; MOUTH SQUAMOUS CELL CARCINOMA; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; SALIVARY GLAND CANCER; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY; TISSUE SECTION; TUMOR BIOPSY; UPREGULATION; BIOSYNTHESIS; CANCER GRADING; CARCINOMA, SQUAMOUS CELL; GENETICS; MIDDLE AGED; MORTALITY; MOUTH NEOPLASMS; NEOPLASMS; PROCEDURES; PROGNOSIS; PROSTATIC NEOPLASMS; SALIVARY GLAND NEOPLASMS; SKIN NEOPLASMS; TUMOR INVASION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHROMATIN ASSEMBLY FACTOR-1; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASMS; PROGNOSIS; PROSTATIC NEOPLASMS; SALIVARY GLAND NEOPLASMS; SKIN NEOPLASMS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84866902489     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms130911044     Document Type: Article

References (48)

1. Feinberg, A.P.; Ohlsson, R.; Henikoff, S. The epigenetic progenitor origin of human cancer. Nat. Rev. Genet. 2006, 7, 21-33.
2. Feinberg, A.P.; Tycko, B. The history of cancer epigenetics. Nat. Rev. Cancer 2004, 4, 143-153.
3. Jones, P.A.; Baylin, S.B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 2002, 3, 415-428.
4. Jones, P.A.; Baylin, S.B. The epigenomics of cancer. Cell 2007, 128, 683-692.
5. Ozanne, S.E.; Constancia, M. Mechanisms of disease: The developmental origins of disease and the role of the epigenotype. Nat. Clin. Pract. Endocrinol. Metab. 2007, 3, 539-546.
6. Schulz, W.A.; Hatina, J. Epigenetics of prostate cancer: Beyond DNA methylation. J. Cell. Mol. Med. 2006, 10, 100-125.
7. Li, L.C. Epigenetics of prostate cancer. Front. Biosci. 2007, 12, 3377-3397.
8. Liu, S.; Ren, S.; Howell, P.; Fodstad, O.; Riker, A.I. Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling. Pigment Cell Melanoma Res. 2008, 21, 545-558.
9. Egger, G.; Liang, G.; Aparicio, A.; Jones, P.A. Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004, 429, 457-463.
10. Heightman, T.D. Therapeutic prospects for epigenetic modulation. Expert Opin. Ther. Targets 2011, 15, 729-740.
11. Sharma, S.K.; Wu, Y.; Steinbergs, N.; Crowley, M.L.; Hanson, A.S.; Casero, R.A.; Woster, P.M. (Bis)urea and (bis)thiourea inhibitors of lysine-specific demethylase 1 as epigenetic modulators. J. Med. Chem. 2010, 53, 5197-5212.
12. Rountree, M.R.; Bachman, K.E.; Herman, J.G.; Baylin, S.B. DNA methylation, chromatin inheritance, and cancer. Oncogene 2001, 20, 3156-3165.
13. Sandoval, J.; Esteller, M. Cancer epigenomics: Beyond genomics. Curr. Opin. Genet. Dev. 2012, 22, 50-55.
14. Kouzarides, T. Chromatin modifications and their function. Cell 2007, 128, 693-705.
15. Ehrenhofer-Murray, A.E. Chromatin dynamics at DNA replication, transcription and repair. Eur. J. Biochem. 2004, 271, 2335-2349.
16. De Koning, L.; Corpet, A.; Haber, J.E.; Almouzni, G. Histone chaperones: An escort network regulating histone traffic. Nat. Struct. Mol. Biol. 2007, 14, 997-1007.
17. Tagami, H.; Ray-Gallet, D.; Almouzni, G.; Nakatani, Y. Histone H3.1 and H3.3 complexes mediate nucleosome assembly pathways dependent or independent of DNA synthesis. Cell 2004, 116, 51-61.
18. Krude, T.; Keller, C. Chromatin assembly during S phase: Contributions from histone deposition, DNA replication and the cell division cycle. Cell. Mol. Life Sci. 2001, 58, 665-672.
19. Ramirez-Parra, E.; Gutierrez, C. The many faces of chromatin assembly factor 1. Trends Plant Sci. 2007, 12, 570-576.
20. Linger, J.G.; Tyler, J.K. Chromatin disassembly and reassembly during DNA repair. Mutat. Res. 2007, 618, 52-64.
21. Gaillard, P.H.; Martini, E.M.; Kaufman, P.D.; Stillman, B.; Moustacchi, E.; Almouzni, G. Chromatin assembly coupled to DNA repair: A new role for chromatin assembly factor 1. Cell 1996, 86, 887-896.
22. Verger, A.; Crossley, M. Chromatin modifiers in transcription and DNA repair. Cell. Mol. Life Sci. 2004, 61, 2154-2162.
23. Staibano, S.; Mascolo, M.; Rocco, A.; Lo Muzio, L.; Ilardi, G.; Siano, M.; Pannone, G.; Vecchione, M.L.; Nugnes, L.; Califano, L. et al. The proliferation marker Chromatin Assembly Factor-1 is of clinical value in predicting the biological behaviour of salivary gland tumours. Oncol. Rep. 2011, 25, 13-22.
24. Mascolo, M.; Vecchione, M.L.; Ilardi, G.; Scalvenzi, M.; Molea, G.; di Benedetto, M.; Nugnes, L.; Siano, M.; de Rosa, G.; Staibano, S. Overexpression of Chromatin Assembly Factor-1/p60 helps to predict the prognosis of melanoma patients. BMC Cancer 2010, 10, 63.
25. Staibano, S.; Mascolo, M.; Mancini, F.P.; Kisslinger, A.; Salvatore, G.; di Benedetto, M.; Chieffi, P.; Altieri, V.; Prezioso, D.; Ilardi, G. et al. Overexpression of chromatin assembly factor-1 (CAF-1) p60 is predictive of adverse behaviour of prostatic cancer. Histopathology 2009, 54, 580-589.
26. Staibano, S.; Mignogna, C.; Lo Muzio, L.; Mascolo, M.; Salvatore, G.; di Benedetto, M.; Califano, L.; Rubini, C.; de Rosa, G. Chromatin assembly factor-1 (CAF-1)-mediated regulation of cell proliferation and DNA repair: A link with the biological behaviour of squamous cell carcinoma of the tongue? Histopathology 2007, 50, 911-919.
27. Polo, S.E.; Theocharis, S.E.; Klijanienko, J.; Savignoni, A.; Asselain, B.; Vielh, P.; Almouzni, G. Chromatin assembly factor-1, a marker of clinical value to distinguish quiescent from proliferating cells. Cancer Res. 2004, 64, 2371-2381.
28. Polo, S.E.; Theocharis, S.E.; Grandin, L.; Gambotti, L.; Antoni, G.; Savignoni, A.; Asselain, B.; Patsouris, E.; Almouzni, G. Clinical significance and prognostic value of chromatin assembly factor-1 overexpression in human solid tumours. Histopathology 2010, 57, 716-724.
29. Chen, Y.; Miller, C.; Mosher, R.; Zhao, X.; Deeds, J.; Morrissey, M.; Bryant, B.; Yang, D.; Meyer, R.; Cronin, F. et al. Identification of cervical cancer markers by cDNA and tissue microarrays. Cancer Res. 2003, 63, 1927-1935.
30. Fons, G.; Burger, M.P.; Ten Kate, F.J.; van der Velden, J. Identification of potential prognostic markers for vulvar cancer using immunohistochemical staining of tissue microarrays. Int. J. Gynecol. Pathol. 2007, 26, 188-193.
31. Gomaa, W.; Ke, Y.; Fujii, H.; Helliwell, T. Tissue microarray of head and neck squamous carcinoma: Validation of the methodology for the study of cutaneous fatty acid-binding protein, vascular endothelial growth factor, involucrin and Ki-67. Virchows Archiv. 2005, 447, 701-709.
32. Su, Y. Immunohistochemical Expressions of Ki-67, Cyclin D1, -Catenin, Cyclooxygenase-2, and epidermal growth factor receptor in human colorectal adenoma: A validation study of tissue microarrays. Cancer Epidemiol. Biomark. Prev. 2006, 15, 1719-1726.
33. Van den Eynden, G.G.; van der Auwera, I.; van Laere, S.; Colpaert, C.G.; van Dam, P.; Merajver, S.; Kleer, C.G.; Harris, A.L.; van Marck, E.A.; Dirix, L.Y. et al. Validation of a tissue microarray to study differential protein expression in inflammatory and non-inflammatory breast cancer. Breast Cancer Res. Treat. 2004, 85, 13-22.
34. Wan, W.H.; Fortuna, M.B.; Furmanski, P. A rapid and efficient method for testing immunohistochemical reactivity of monoclonal antibodies against multiple tissue samples simultaneously. J. Immunol. Methods 1987, 103, 121-129.
35. Kononen, J.; Bubendorf, L.; Kallioniemi, A.; Barlund, M.; Schraml, P.; Leighton, S.; Torhorst, J.; Mihatsch, M.J.; Sauter, G.; Kallioniemi, O.P. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 1998, 4, 844-847.
36. Monteiro, L.S.; Diniz-Freitas, M.; Garcia-Caballero, T.; Forteza, J.; Fraga, M. EGFR and Ki-67 expression in oral squamous cell carcinoma using tissue microarray technology. J. Oral Pathol. Med. 2010, 39, 571-578.
37. Boone, J.; van Hillegersberg, R.; van Diest, P.J.; Offerhaus, G.J.; Rinkes, I.H.; Kate, F.J. Validation of tissue microarray technology in squamous cell carcinoma of the esophagus. Virchows Arch. 2008, 452, 507-514.
38. Hecht, J.L.; Kotsopoulos, J.; Gates, M.A.; Hankinson, S.E.; Tworoger, S.S. Validation of tissue microarray technology in ovarian cancer: Results from the Nurses' Health Study. Cancer Epidemiol. Biomark. Prev. 2008, 17, 3043-3050.
39. Alkushi, A. Validation of tissue microarray biomarker expression of breast carcinomas in Saudi women. Hematol. Oncol. Stem Cell Ther. 2009, 2, 394-398.
40. Cunha, K.S.; Caruso, A.C.; Goncalves, A.S.; Bernardo, V.G.; Pires, A.R.; da Fonseca, E.C.; de Faria, P.A.; da Silva, L.E.; Geller, M.; de Moura-Neto, R.S.; et al. Validation of tissue microarray technology in malignant peripheral nerve sheath tumours. J. Clin. Pathol. 2009, 62, 629-633.
41. Camp, R.L.; Neumeister, V.; Rimm, D.L. A decade of tissue microarrays: Progress in the discovery and validation of cancer biomarkers. J. Clin. Oncol. 2008, 26, 5630-5637.
42. Sullivan, C.A.; Chung, G.G. Biomarker validation: In situ analysis of protein expression using semiquantitative immunohistochemistry-based techniques. Clin. Colorectal. Cancer 2008, 7, 172-177.
43. Giltnane, J.M.; Rimm, D.L. Technology insight: Identification of biomarkers with tissue microarray technology. Nat. Clin. Pract. Oncol. 2004, 1, 104-111.
44. Wang, S.L.; Yang, C.H.; Chen, H.H.; Chai, C.Y. A simple and economical method for the manual construction of well-aligned tissue arrays. Pathol. Res. Pract. 2006, 202, 485-486.
45. Eguiluz, C.; Viguera, E.; Millan, L.; Perez, J. Multitissue array review: A chronological description of tissue array techniques, applications and procedures. Pathol. Res. Pract. 2006, 202, 561-568.
46. Edge, S.B.; Byrd, D.R.; Compton, C.C.; Fritz, A.G.; Greene, F.L.; Trotti, A. AJCC Cancer Staging Manual, 7th ed.; Springer: New York, NY, USA, 2010; p. 130.
47. Hoos, A.; Urist, M.J.; Stojadinovic, A.; Mastorides, S.; Dudas, M.E.; Leung, D.H.; Kuo, D.; Brennan, M.F.; Lewis, J.J.; Cordon-Cardo, C. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am. J. Pathol. 2001, 158, 1245-1251.
48. Kundel, H.L.; Polansky, M. Measurement of observer agreement. Radiology 2003, 228, 303-308.